• Careers
  • Contact
Tavanta Tavanta
  • Company
    • About
    • Leadership
    • Partnering
    • Careers
    • Contact
  • Focus
    • Approach
    • Technology Platforms
    • Publications
  • Pipeline
    • Development Pipeline
    • TAVT-45
    • TAVT-119
    • TAVT-18
    • Early Development Programs
  • Newsroom
    • Press Releases
Select Page
Tavanta
    • Company
      • About
      • Leadership
      • Partnering
      • Careers
      • Contact
    • Focus
      • Approach
      • Technology Platforms
      • Publications
    • Pipeline
      • Development Pipeline
      • TAVT-45
      • TAVT-119
      • TAVT-18
      • Early Development Programs
    • Newsroom
      • Press Releases
    • Careers
    • Contact

Press Releases

Check out the latest news from Tavanta

May 02, 2018

Best in Class Erectile Dysfunction Drug – DRGT announces dose escalation study results of its Super-Tadalafil DRGT-99

October 05, 2017

DRGT announces results of Phase I study expanding clinical utility of the drug Sirolimus utilizing the company’s novel Super-API technology platform

December 19, 2016

DRGT’s novel Celecoxib composition – opportunity for low dose, immediate onset of pain relief with the only NSAID COX-2 inhibitor on the market

December 14, 2016

Dr. Philip Kantoff – leading expert in clinical oncology and prostate cancer joins DRGT as Senior Clinical Advisor

December 09, 2016

DRGT’s novel Abiraterone Acetate composition provides opportunity for dose reduction and increased efficacy in prostate cancer

June 23, 2015

Quotient Clinical Begins Prostate Cancer Project for Druggability Technologies

December 05, 2013

Druggability Technologies enters into a strategic collaboration with Bayer HealthCare

<<12

Who We Are

LEARN ABOUT TAVANTA

COMPANY

  • About
  • Leadership
  • Partnering
  • Careers
  • Contact

FOCUS

  • Approach
  • Technology Platforms
  • Publications

PIPELINE

  • Development Pipeline
  • TAVT-45
  • TAVT-119
  • TAVT-18
  • Early Development Programs

NEWSROOM

  • Press Releases
  • Privacy Policy
  • Terms of Use
Tavanta
©2020 Tavanta Therapeutics
  • Privacy Policy
  • Terms of Use

This site uses cookies to provide a better browsing experience. More information can be found on our Privacy Policy page.

ACCEPT